A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Clinical trial NCT01063816 · COMPLETED
Trial details
- NCT number
- NCT01063816
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2016-08-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.